Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2,602.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 85,462 shares of the financial services provider’s stock after purchasing an additional 82,300 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in CME Group were worth $18,857,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in the stock. Harbor Capital Advisors Inc. boosted its stake in CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after buying an additional 45 shares during the last quarter. CVA Family Office LLC raised its holdings in shares of CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after acquiring an additional 46 shares during the period. Lester Murray Antman dba SimplyRich boosted its position in shares of CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after acquiring an additional 50 shares during the last quarter. Zions Bancorporation N.A. grew its holdings in shares of CME Group by 3.7% in the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after purchasing an additional 54 shares during the period. Finally, Quent Capital LLC increased its position in CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after purchasing an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research firms have weighed in on CME. Bank of America boosted their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. TD Cowen assumed coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. Morgan Stanley raised their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Deutsche Bank Aktiengesellschaft decreased their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $224.47.
CME Group Stock Performance
Shares of CME stock opened at $238.00 on Monday. The firm has a 50 day moving average of $225.55 and a two-hundred day moving average of $211.96. The stock has a market capitalization of $85.77 billion, a PE ratio of 25.03, a P/E/G ratio of 5.49 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $238.97.
CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the business posted $2.25 earnings per share. CME Group’s revenue was up 18.4% compared to the same quarter last year. On average, research analysts predict that CME Group Inc. will post 10.22 EPS for the current fiscal year.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is presently 48.37%.
Insider Buying and Selling
In related news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Sunil Cutinho sold 4,500 shares of CME Group stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. This trade represents a 14.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 8,028 shares of company stock worth $1,811,681. Company insiders own 0.30% of the company’s stock.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- What Do S&P 500 Stocks Tell Investors About the Market?
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- How to Invest in Biotech Stocks
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.